News | October 02, 2013

Elekta Opens Global Education Center for Oncology and Neuroscience Professionals

Learning and Innovation Center (LINC) to draw thousands to Atlanta

Elekta Learning and Innovation Center Atlanta ASTRO 2013 Oncology Neuroscience

October 2, 2013 — Elekta unveiled a state-of-the-art learning center at its North American headquarters, in conjunction with the 55th Annual Meeting of the American Society for Radiation Oncology (ASTRO), which was held in Atlanta.

The Learning and Innovation Center (LINC) is expected to draw clinicians, researchers and health IT professionals to the city for education, training and collaboration on Elekta's solutions for treating cancer and brain disorders. The LINC also serves as a tangible introduction to Elekta, with interactive displays highlighting the company's achievements in cancer treatment.

"The creation of the LINC consolidates a wealth of educational resources that encompass all of our cancer management competencies," says Jay Hoey, executive vice president, region North America. "Atlanta is an ideal location for this, with easy airport access to North America and the world, a thriving metropolitan area and a wealth of other health care and educational resources."

The 25,000-square-foot facility, set among a park-like setting, incorporates the latest adult learning principles and technology, and is equipped with actual working systems of virtually every Elekta solution to support hands-on learning. These solutions represent Elekta's oncology, software, brachytherapy, neuroscience and imaging products, including the new Versa HD linear accelerator and Leksell Gamma Knife Perfexion. Enhancing the experience, students have access to the Versa HD vault, which is large enough for hands-on learning.

"This is a beautiful facility that brings numerous benefits to Atlanta and the state of Georgia," says David Hartnett, vice president, Economic Development, Bioscience-Health IT, Metro Atlanta Chamber. "Not only does it provide an ideal setting for learning, but the LINC has educational exhibits that demonstrate Elekta's leadership in advancing cancer care. This facility enhances and solidifies Georgia's leadership position in the fields of cancer treatment and research."

Related Content

Sectra Providing Centralized Regional Solution for Digital Pathology in the U.K.
News | Digital Pathology | June 14, 2019
Sectra has signed a five-year contract with North Tees and Hartlepool National Health System (NHS) Foundation Trust for...
University Medical Center Groningen Performs First Automatic Log-based Proton Therapy Patient QA
News | Proton Therapy | June 14, 2019
IBA announced the physics team of University Medical Center Groningen (UMCG) in the Netherlands has developed and...
ASTRO Applauds New Prior Authorization Legislation
News | Radiation Therapy | June 07, 2019
The American Society for Radiation Oncology (ASTRO) released a statement applauding Congress’s introduction of...
IBA Dosimetry Launches myQA iON
News | Quality Assurance (QA) | June 07, 2019
IBA (Ion Beam Applications S.A.) announced the launch of myQA iON at the 2019 Particle Therapy Co-Operative Group (...
RefleXion Opens New Manufacturing Facility for Biology-guided Radiotherapy Platform
News | Radiation Therapy | May 31, 2019
RefleXion Medical recently announced the opening of its new manufacturing facility at its headquarters in Hayward,...
A set of synthetic CT images created from T1 and T2 weighted MR imaging of a prostate/rectum phantom at Henry Ford Hospital. The hospital is one of the research centers developing  synthetic CT imaging for treatment planning to avoid the need for CT scans of a patient just for treatment planning purposes when they already have a more detailed soft tissue MRI exam of  the anatomy.

A set of synthetic CT images created from T1 and T2 weighted MR imaging of a prostate/rectum phantom at Henry Ford Hospital. The hospital is one of the research centers developing synthetic CT imaging for treatment planning to avoid the need for CT scans of a patient just for treatment planning purposes when they already have a more detailed soft tissue MRI exam of the anatomy.

Feature | Radiation Oncology | May 29, 2019 | By Jeff Zagoudis
Vast Majority of Heavy Smokers Not Screened for Lung Cancer
News | Lung Cancer | May 29, 2019
Out of more than 7 million current and former heavy smokers, only 1.9 percent were screened for lung cancer in 2016...
Accuray Radixact

Accuray Radixact

Feature | Radiation Therapy | May 29, 2019 | By Jeff Zagoudis
While radiation therapy as a disciplin
Sponsored Content | Case Study | Radiation Therapy | May 29, 2019
The so-called “Grey Tsunami” of baby boomers using healthcare services isn’t taking the Radiation Medicine Program at
New Blood Test Detects Colorectal Cancer Recurrence Up to 16.5 Months Earlier
News | Oncology Diagnostics | May 28, 2019
A new clinical study shows that Natera's Signatera test identified colorectal cancer recurrence up to 16.5 months...